{"id":"https://openalex.org/W4361960175","doi":"https://doi.org/10.1158/1078-0432.c.6520260","title":"Data from A Phase I Pharmacokinetic and Pharmacodynamic Study of Dalotuzumab (MK-0646), an Anti-Insulin-like Growth Factor-1 Receptor Monoclonal Antibody, in Patients with Advanced Solid Tumors","display_name":"Data from A Phase I Pharmacokinetic and Pharmacodynamic Study of Dalotuzumab (MK-0646), an Anti-Insulin-like Growth Factor-1 Receptor Monoclonal Antibody, in Patients with Advanced Solid Tumors","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361960175","doi":"https://doi.org/10.1158/1078-0432.c.6520260"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6520260","doi":"https://doi.org/10.1158/1078-0432.c.6520260","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6520260","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1078-0432.c.6520260","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068234157","display_name":"Francesco Atzori","orcid":"https://orcid.org/0000-0002-8211-0363","observed_orcids":["https://orcid.org/0000-0002-8211-0363"]},"institutions":[{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]},{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Francesco Atzori","raw_affiliation_strings":["Vall d'Hebron University Hospital, Universitat Aut\u00f2noma de Barcelona, Barcelona;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vall d'Hebron University Hospital, Universitat Aut\u00f2noma de Barcelona, Barcelona;","institution_ids":["https://openalex.org/I123044942","https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015190461","display_name":"Josep M. Tabernero","orcid":"https://orcid.org/0000-0002-2495-8139","observed_orcids":["https://orcid.org/0000-0002-2495-8139"]},"institutions":[{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]},{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Josep Tabernero","raw_affiliation_strings":["Vall d'Hebron University Hospital, Universitat Aut\u00f2noma de Barcelona, Barcelona;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vall d'Hebron University Hospital, Universitat Aut\u00f2noma de Barcelona, Barcelona;","institution_ids":["https://openalex.org/I123044942","https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091727687","display_name":"Andr\u00e8s M.R. Cervantes","orcid":"https://orcid.org/0000-0003-3806-3691","observed_orcids":["https://orcid.org/0000-0003-3806-3691","https://orcid.org/0000-0003-4644-3977"]},"institutions":[{"id":"https://openalex.org/I16097986","display_name":"Universitat de Val\u00e8ncia","ror":"https://ror.org/043nxc105","country_code":"ES","type":"education","lineage":["https://openalex.org/I16097986"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Andr\u00e9s Cervantes","raw_affiliation_strings":["Hos-pital Cl\u00ednico, University of Valencia, Valencia, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hos-pital Cl\u00ednico, University of Valencia, Valencia, Spain;","institution_ids":["https://openalex.org/I16097986"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018105485","display_name":"Ludmila Prudkin","orcid":"https://orcid.org/0000-0001-5747-0706","observed_orcids":["https://orcid.org/0000-0001-5747-0706"]},"institutions":[{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]},{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Ludmila Prudkin","raw_affiliation_strings":["Vall d'Hebron University Hospital, Universitat Aut\u00f2noma de Barcelona, Barcelona;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vall d'Hebron University Hospital, Universitat Aut\u00f2noma de Barcelona, Barcelona;","institution_ids":["https://openalex.org/I123044942","https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107840236","display_name":"Jordi Andreu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]},{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jordi Andreu","raw_affiliation_strings":["Vall d'Hebron University Hospital, Universitat Aut\u00f2noma de Barcelona, Barcelona;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vall d'Hebron University Hospital, Universitat Aut\u00f2noma de Barcelona, Barcelona;","institution_ids":["https://openalex.org/I123044942","https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037247287","display_name":"Edith Rodr\u00edguez-Braun","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I16097986","display_name":"Universitat de Val\u00e8ncia","ror":"https://ror.org/043nxc105","country_code":"ES","type":"education","lineage":["https://openalex.org/I16097986"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Edith Rodr\u00edguez-Braun","raw_affiliation_strings":["Hos-pital Cl\u00ednico, University of Valencia, Valencia, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hos-pital Cl\u00ednico, University of Valencia, Valencia, Spain;","institution_ids":["https://openalex.org/I16097986"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Amparo Domingo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I16097986","display_name":"Universitat de Val\u00e8ncia","ror":"https://ror.org/043nxc105","country_code":"ES","type":"education","lineage":["https://openalex.org/I16097986"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Amparo Domingo","raw_affiliation_strings":["Hos-pital Cl\u00ednico, University of Valencia, Valencia, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hos-pital Cl\u00ednico, University of Valencia, Valencia, Spain;","institution_ids":["https://openalex.org/I16097986"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056123841","display_name":"Jorge Guijarro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I16097986","display_name":"Universitat de Val\u00e8ncia","ror":"https://ror.org/043nxc105","country_code":"ES","type":"education","lineage":["https://openalex.org/I16097986"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jorge Guijarro","raw_affiliation_strings":["Hos-pital Cl\u00ednico, University of Valencia, Valencia, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hos-pital Cl\u00ednico, University of Valencia, Valencia, Spain;","institution_ids":["https://openalex.org/I16097986"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Cristina Gamez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802050225","display_name":"Bellvitge University Hospital","ror":"https://ror.org/00epner96","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I2802050225","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Cristina Gamez","raw_affiliation_strings":["Bellvitge Hospital, Barcelona;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bellvitge Hospital, Barcelona;","institution_ids":["https://openalex.org/I2802050225"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031165814","display_name":"Jordi Ahnert Rodon","orcid":"https://orcid.org/0000-0001-6467-3632","observed_orcids":["https://orcid.org/0000-0001-6467-3632","https://orcid.org/0000-0003-2234-5248"]},"institutions":[{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]},{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jordi Rodon","raw_affiliation_strings":["Vall d'Hebron University Hospital, Universitat Aut\u00f2noma de Barcelona, Barcelona;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vall d'Hebron University Hospital, Universitat Aut\u00f2noma de Barcelona, Barcelona;","institution_ids":["https://openalex.org/I123044942","https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001910485","display_name":"Serena Di Cosimo","orcid":"https://orcid.org/0000-0002-4666-8052","observed_orcids":["https://orcid.org/0000-0002-4666-8052"]},"institutions":[{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]},{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Serena Di Cosimo","raw_affiliation_strings":["Vall d'Hebron University Hospital, Universitat Aut\u00f2noma de Barcelona, Barcelona;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vall d'Hebron University Hospital, Universitat Aut\u00f2noma de Barcelona, Barcelona;","institution_ids":["https://openalex.org/I123044942","https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017024703","display_name":"Holly Brown","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Holly Brown","raw_affiliation_strings":["Merck, Whitehouse Station, New Jersey;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck, Whitehouse Station, New Jersey;","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jason Clark","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason Clark","raw_affiliation_strings":["Merck, Whitehouse Station, New Jersey;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck, Whitehouse Station, New Jersey;","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103498404","display_name":"James S. Hardwick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James S. Hardwick","raw_affiliation_strings":["Merck, Whitehouse Station, New Jersey;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck, Whitehouse Station, New Jersey;","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027438799","display_name":"Robert A. Beckman","orcid":"https://orcid.org/0000-0003-0098-9210","observed_orcids":["https://orcid.org/0000-0003-0098-9210"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert A. Beckman","raw_affiliation_strings":["Merck, Whitehouse Station, New Jersey;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck, Whitehouse Station, New Jersey;","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075831958","display_name":"William D. Hanley","orcid":"https://orcid.org/0009-0003-0319-3338","observed_orcids":["https://orcid.org/0009-0003-0319-3338"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William D. Hanley","raw_affiliation_strings":["Merck, Whitehouse Station, New Jersey;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck, Whitehouse Station, New Jersey;","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072906560","display_name":"Karl Hsu","orcid":"https://orcid.org/0000-0003-3137-1202","observed_orcids":["https://orcid.org/0000-0003-3137-1202"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karl Hsu","raw_affiliation_strings":["Merck, Whitehouse Station, New Jersey;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck, Whitehouse Station, New Jersey;","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053069942","display_name":"Emiliano Calvo","orcid":"https://orcid.org/0000-0003-4921-829X","observed_orcids":["https://orcid.org/0000-0003-4921-829X"]},"institutions":[{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]},{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Emiliano Calvo","raw_affiliation_strings":["Vall d'Hebron University Hospital, Universitat Aut\u00f2noma de Barcelona, Barcelona;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vall d'Hebron University Hospital, Universitat Aut\u00f2noma de Barcelona, Barcelona;","institution_ids":["https://openalex.org/I123044942","https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055862157","display_name":"Susana Rosell\u00f3","orcid":"https://orcid.org/0000-0003-3915-4130","observed_orcids":["https://orcid.org/0000-0003-3915-4130"]},"institutions":[{"id":"https://openalex.org/I16097986","display_name":"Universitat de Val\u00e8ncia","ror":"https://ror.org/043nxc105","country_code":"ES","type":"education","lineage":["https://openalex.org/I16097986"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Susana Rosell\u00f3","raw_affiliation_strings":["Hos-pital Cl\u00ednico, University of Valencia, Valencia, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hos-pital Cl\u00ednico, University of Valencia, Valencia, Spain;","institution_ids":["https://openalex.org/I16097986"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002660940","display_name":"Ronald B. Langdon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ronald B. Langdon","raw_affiliation_strings":["Merck, Whitehouse Station, New Jersey;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck, Whitehouse Station, New Jersey;","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004300577","display_name":"Jose M Baselga","orcid":"https://orcid.org/0000-0003-1361-4063","observed_orcids":["https://orcid.org/0000-0003-1361-4063"]},"institutions":[{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES","US"],"is_corresponding":false,"raw_author_name":"Jos\u00e9 Baselga","raw_affiliation_strings":["Massachusetts General Hospital Cancer Cen-ter, Boston, Massachusetts","Vall d'Hebron University Hospital, Universitat Aut\u00f2noma de Barcelona, Barcelona;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital Cancer Cen-ter, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Vall d'Hebron University Hospital, Universitat Aut\u00f2noma de Barcelona, Barcelona;","institution_ids":["https://openalex.org/I123044942","https://openalex.org/I4210127641"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/igf-1-receptor","display_name":"IGF-1 receptor","score":0.9449999928474426},{"id":"https://openalex.org/keywords/igf1r-inhibitors","display_name":"IGF1R inhibitors","score":0.7559999823570251},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.9169999957084656},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9110000133514404},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9990000128746033},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.7459999918937683},{"id":"https://openalex.org/keywords/chemotherapy-refractory-cancer","display_name":"chemotherapy-refractory cancer","score":0.8080000281333923},{"id":"https://openalex.org/keywords/hyperglycemia","display_name":"hyperglycemia","score":0.8289999961853027},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.7400000095367432},{"id":"https://openalex.org/keywords/recommended-phase-ii-dose","display_name":"recommended phase 2 dose","score":0.7459999918937683},{"id":"https://openalex.org/keywords/ki-67","display_name":"Ki-67","score":0.7279999852180481},{"id":"https://openalex.org/keywords/ewing-sarcoma","display_name":"Ewing sarcoma","score":0.7549999952316284},{"id":"https://openalex.org/keywords/dosing-regimen","display_name":"dosing regimen","score":0.4350000023841858}],"concepts":[{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.7285352349281311},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6970245838165283},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.5721952319145203},{"id":"https://openalex.org/C2780689927","wikidata":"https://www.wikidata.org/wiki/Q24766801","display_name":"Insulin-like growth factor","level":4,"score":0.5315045714378357},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5302823185920715},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.43869221210479736},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42845478653907776},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.421223521232605},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.41427484154701233},{"id":"https://openalex.org/C2775960820","wikidata":"https://www.wikidata.org/wiki/Q408378","display_name":"Growth factor","level":3,"score":0.24628153443336487},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.14458519220352173},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.09892436861991882},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.c.6520260","doi":"https://doi.org/10.1158/1078-0432.c.6520260","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6520260","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6520260","doi":"https://doi.org/10.1158/1078-0432.c.6520260","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6520260","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W1974223107","https://openalex.org/W1978103469","https://openalex.org/W1978922759","https://openalex.org/W1993199678","https://openalex.org/W2008585163","https://openalex.org/W2020636054","https://openalex.org/W2021688157","https://openalex.org/W2023180106","https://openalex.org/W2031964028","https://openalex.org/W2038596166","https://openalex.org/W2057418848","https://openalex.org/W2058140056","https://openalex.org/W2062826169","https://openalex.org/W2066917552","https://openalex.org/W2072201354","https://openalex.org/W2089171551","https://openalex.org/W2093221289","https://openalex.org/W2094025115","https://openalex.org/W2095293611","https://openalex.org/W2105133185","https://openalex.org/W2108468456","https://openalex.org/W2117350664","https://openalex.org/W2126783165","https://openalex.org/W2129727061","https://openalex.org/W2136137911","https://openalex.org/W2149218373","https://openalex.org/W2150081825","https://openalex.org/W2152274262","https://openalex.org/W2167156722","https://openalex.org/W2244786128","https://openalex.org/W2335873700","https://openalex.org/W2339785346","https://openalex.org/W2538590401"],"related_works":["https://openalex.org/W2166964481","https://openalex.org/W2253720089","https://openalex.org/W2527266916","https://openalex.org/W2538590401","https://openalex.org/W2006827588","https://openalex.org/W2401973235","https://openalex.org/W2364373762","https://openalex.org/W2597431707","https://openalex.org/W2071656916","https://openalex.org/W4361945442"],"abstract_inverted_index":{"Abstract":[0],"Purpose:":[1],"Insulin-like":[2],"growth":[3],"factor-1":[4],"receptor":[5,33,184],"(IGF-1R)":[6],"mediates":[7],"cellular":[8],"processes":[9],"in":[10,141,180,198,249],"cancer":[11],"and":[12,43,51,55,81,99,102,172,186,219,228,246,252,260],"has":[13],"been":[14],"proposed":[15],"as":[16],"a":[17,23,57,126,207],"therapeutic":[18],"target.":[19],"Dalotuzumab":[20,235],"(MK-0646)":[21],"is":[22],"humanized":[24],"IgG1":[25],"monoclonal":[26],"antibody":[27],"that":[28],"binds":[29],"to":[30,39,72,134,138],"IGF-1R":[31,68,243],"preventing":[32],"activation.":[34],"This":[35],"study":[36],"was":[37,92,123,129,157,164,170,236],"designed":[38],"evaluate":[40],"the":[41,48,223],"safety":[42],"tolerability":[44],"of":[45,75],"dalotuzumab,":[46],"determine":[47],"pharmacokinetic":[49],"(PK)":[50],"pharmacodynamic":[52],"(PD)":[53],"profiles,":[54],"identify":[56],"recommended":[58,212],"phase":[59,213],"II":[60,214],"dose.":[61],"Experimental":[62],"Design:":[63],"Patients":[64],"with":[65,114,203],"tumors":[66,117],"expressing":[67],"protein":[69],"were":[70,106,118,175,189,216],"allocated":[71],"dose-escalating":[73],"cohorts":[74],"three":[76,199],"or":[77,88,148,160],"more":[78,149,165,265],"patients":[79,113],"each":[80],"received":[82],"intravenous":[83],"dalotuzumab":[84,153],"weekly,":[85,224],"every":[86,225,229],"2":[87],"3":[89,135],"weeks.":[90],"Plasma":[91],"collected":[93,107],"for":[94,108,222],"PK":[95],"analysis.":[96],"Paired":[97],"baseline":[98],"on-treatment":[100],"skin":[101],"tumor":[103,181],"biopsy":[104],"samples":[105],"PD":[109],"analyses.":[110],"Results:":[111],"Eighty":[112],"chemotherapy-refractory":[115],"solid":[116],"enrolled.":[119],"One":[120,201],"dose-limiting":[121],"toxicity":[122],"noted,":[124],"but":[125],"maximum-tolerated":[127],"dose":[128,146,177],"not":[130],"identified.":[131],"Grade":[132],"1":[133],"hyperglycemia,":[136],"responsive":[137],"metformin,":[139],"occurred":[140,197],"15":[142],"(19%)":[143],"patients.":[144,200],"At":[145],"levels":[147],"than":[150,166],"5":[151],"mg/kg,":[152],"mean":[154,162],"terminal":[155,262],"half-life":[156,263],"95":[158],"hours":[159],"more,":[161],"Cmin":[163],"25":[167],"\u03bcg/mL,":[168],"clearance":[169,258],"constant,":[171],"serum":[173],"exposures":[174],"approximately":[176],"proportional.":[178],"Decreases":[179],"IGF-1R,":[182],"downstream":[183],"signaling,":[185],"Ki67":[187],"expression":[188],"observed.":[190],"18F-Fluorodeoxy-glucose":[191],"positron":[192],"emission":[193],"tomography":[194],"metabolic":[195],"responses":[196],"patient":[202],"Ewing's":[204],"sarcoma":[205],"showed":[206,253],"mixed":[208],"radiologic":[209],"response.":[210],"The":[211,256],"doses":[215],"10,":[217],"20,":[218],"30":[220],"mg/kg":[221],"other":[226],"week,":[227],"third":[230],"week":[231],"schedules,":[232],"respectively.":[233],"Conclusions:":[234],"generally":[237],"well-tolerated,":[238],"exhibited":[239],"dose-proportional":[240],"PK,":[241],"inhibited":[242],"pathway":[244],"signaling":[245],"cell":[247],"proliferation":[248],"treated":[250],"tumors,":[251],"clinical":[254],"activity.":[255],"low":[257],"rate":[259],"long":[261],"support":[264],"extended":[266],"dosing":[267],"intervals.":[268],"Clin":[269],"Cancer":[270],"Res;":[271],"17(19);":[272],"6304\u201312.":[273],"\u00a92011":[274],"AACR.":[275]},"counts_by_year":[],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2023-04-05T00:00:00"}